Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Epidemiology and Infection|April 16, 2011
Meningococcal disease in Asia: an under-recognized public health burdenA Vyse, J M Wolter, J Chen, et al.
Cancer Research|June 1, 1986
Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric studyJ H von Roenn, S M Kheir, J M Wolter, et al.
Cancer|December 15, 1982
A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcomaD A Schoenfeld, C Rosenbaum, J Horton, et al.
Seminars in Oncology|December 1, 1986
Megestrol acetate: first-line therapy for advanced breast cancerP A Johnson, P D Bonomi, K M Anderson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Ten-year follow-up study of premenopausal women with metastatic breast cancer: an Eastern Cooperative Oncology Group studyG Falkson, C Holcroft, R S Gelman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1987
Treatment of metastatic breast cancer in premenopausal women using CAF with or without oophorectomy: an Eastern Cooperative Oncology Group StudyG Falkson, R S Gelman, D C Tormey, et al.
Seminars in Oncology|April 1, 1988
Sequential hormone therapy for advanced breast cancerJ H Von Roenn, P D Bonomi, M Gale, et al.
American Journal of Clinical Oncology|December 1, 1988
A pilot study of the Functional Living Index-Cancer (FLIC) Scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group studyD M Finkelstein, B R Cassileth, P D Bonomi, et al.
Cancer Investigation|January 1, 1990
Phase II trial of methylglyoxal-bis(guanylhydrazone) (MGBG) in patients with refractory multiple myeloma: an Eastern Cooperative Oncology Group (ECOG) studyJ N Winter, P S Ritch, S T Rosen, et al.
Cancer Treatment Reports|July 1, 1983
Progesterone receptor level as a predictor of response to megestrol acetate in advanced breast cancer: a retrospective studyP A Johnson, P D Bonomi, K M Anderson, et al.
Pageof 3